Laboratory cross-comparison of tumor BRCA1/2 analysis in a multicenter epithelial ovarian cancer series: The BORNEO GEICO60-0 study.
Por:
Romero, I, Oaknin, A, Garcia-Casado, Z, Marquez, R, Esteban, A, Gallego, A, Sanchez, A, Segura, C, Alarcon, J, Barretina-Ginesta, M, Vazquez, I, Farinas-Madrid, L, Cueva, J, Matito, J, Poveda, A, Guerrero, J and Vivancos, A
Publicada:
20 may 2020
Resumen:
Filiaciones:
Inst Valenciano Oncol, Valencia, Spain.
Vall dHebron Univ Hosp, Vall dHebron Inst Oncol VHIO, Barcelona, Spain.
Inst Valenciano Oncol IVO, Lab Mol Biol, Valencia, Spain.
MD Anderson Canc Ctr Madrid, Med Oncol Dept, Madrid, Spain.
HCU Lozano Blesa, Barcelona, Spain.
Hosp Univ La Paz, Madrid, Spain.
Hosp Gen Univ Elche, Alicante, Spain.
XARXA TECLA, Tarragona, Spain.
Hosp Son Espases, Palma De Mallorca, Spain.
GEICO, Girona, Spain.
Catalan Inst Oncol, Med Oncol Dept, Girona, Spain.
Hosp Univ Cent Asturias, Oviedo, Spain.
Hosp Clin Unv Santiago, La Coruna, Spain.
Vall dHebron Inst Oncol VHIO, Canc Genom Grp, Barcelona, Spain.
Inst Valenciano Oncol, Lab Mol Biol, Valencia, Spain.
Vall dHebron Inst Oncol VHIO, Lab & Mol Pathol Lab, Barcelona, Spain.
|